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Abstract: Endobronchial lipoma is a rare benign lung tumor. Here
we present two cases. One case is the first report of the association
of and endobronchial lipoma with a hilar lipoma. We discuss the
epidemiology, difficulties in establishing the diagnosis, and the
management of this rare condition.
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Benign lung tumors are a diverse group of tumors. Theyrepresent 2 to 5% of all lung tumors. Ninety percent of
them are adenomas and hamartomas. Although lipomas are
the most frequent tumors of the body, ‘pulmonary’ lipomas
are very rare. Endobronchial lipomas have an incidence of 0.1
to 0.5% of all lung tumors.
Here we present two case-reports. One of them is to our
knowledge, the first case-report from a patient with an endo-
bronchial lipoma associated with a hilar lipoma.
Case 1
A 41-year-old man presented to our department with
vague thoracic pain. He had no other respiratory symptoms
(i.e., no dyspnea, cough, wheezing, or hemoptysis).
During his childhood he received treatment for tuber-
culosis in Morocco. The patient also underwent a videoscopic
assisted thoracoscopy with talc poudrage 8 years earlier
because of a right-sided pneumothorax. After this pneumo-
thorax he stopped smoking.
Clinical examination upon presentation was unremark-
able. A chest radiograph revealed an enlargement of the right
hilus. Hematological and biochemistry blood values were
normal. Pulmonary function tests were also normal.
Computed tomography (CT) of the thorax showed a
hilar mass on the right side, with the density of fat (–100 HU),
identified as a hilar lipoma (Figure 1A). There was also a
large cystic structure in the right upper lobe, adjacent to the
right hilus. Positron Emission Tomography scan showed no
uptake of the hilar mass. A bronchoscopy revealed a yellow
mass in the right lower lobe bronchus (Figure 2A). An
identical, but smaller lesion was seen in the right upper lobe
bronchus. The endobronchial tumor in the right lower lobe
bronchus was resected during rigid bronchoscopy.
The histologic specimen showed a fragment of respi-
ratory epithelium without cytonuclear atypia. There was fat
tissue located centrally. The fat tissue consisted of univacu-
olar mature fat cells. They were uniform in form and size, so
the diagnosis of an endobronchial lipoma was made (Figure 3A).
His thoracic discomfort was not deemed related to the
endobronchial or hilar lipoma, and resolved spontaneously.
Case 2
A 73-year-old woman was initially hospitalized in
the Department of Urology for a transurethral resection of
a bladder epithelioma. Postoperatively she developed
cough, fever, and became dyspnoeic. Her clinical history
was significant for smoking (50 pack years of cigarettes),
an appendectomy, and a hysterectomy.
On clinical examination there were some crackles over the
lower lobe of the right lung; her pulse was 74/min, had a blood
pressure of 173/85 mm Hg, and a temperature of 38.6°C.
The patient was referred to the Department of Pneu-
mology for further investigation. A chest radiograph
showed atelectasis of the right lower lobe and pleural
effusion. A CT-scan was performed and showed an obstruc-
tion of the right intermediate bronchus with retro-obstructive
atelectasis of the right lower lobe and some pleural effusion
(Figure 1B). Furthermore, there were enlarged mediastinal
and hilar lymph nodes.
Videobronchoscopy revealed a polypoid endobronchial
tumor obstructing the intermediate bronchus (Figure 2B).
Forceps biopsy of this lesion during flexible bronchoscopy
was difficult due to the movement of the polyp and the
firmness of the tissue. Pathologic examination of these bron-
chial biopsies was normal.
Because of the clinical suspicion of an underlying
malignancy and the presence of enlarged lymph nodes on
CT-scan, a cervical mediastinoscopy was performed. Patho-
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logic examination of the paratracheal nodes showed reactive
lymphoid tissue without evidence for malignancy.
To obtain a definite histologic diagnosis of the endo-
bronchial lesion the polyp was finally resected endoscopically
with a rigid bronchoscope.
The histologic specimen (Figure 3B) showed multi-
ple fragments bordered with pseudostratified ciliated co-
lumnar epithelium to one side. The stroma was focally
infiltrated by lymphocytes and plasma cells. Deeper, there
was normally differentiated adipose tissue, consisting of
adult adipocytes. There was a varying degree of fibrosis.
The specimen was identified as an endobronchial lipoma.
To date, nearly 2 years after her initial diagnosis, there are
no signs of any recurrence of her endobronchial lipoma, al-
though we did not perform a repeat bronchoscopy.
DISCUSSION
Most of lung tumors are malignant (either primary
bronchial carcinomas or metastatic lesions). Only 5% of all
lung tumors are benign. Ninety percent of these benign
lesions are adenomas (mucous cell adenoma, pleomorphic
adenoma, and oncocytoma) or hamartomas.
Although lipoma is the most common tumor of the
body, endobronchial lipomas are extremely rare. They are
benign tumors, with an incidence reported to range from
only 0.1 to 0.5% in all lung tumors.1,2 They are probably
one-sided developments of the mixed mesenchymoma (so-
called hamartoma).3 They have no premalignant connota-
tion. Lipomas, as benign pulmonary tumors, can be found
endobronchially, intrapulmonary, and mediastinal.
FIGURE 1. CT thorax. A. Case 1.
There is a hilar mass on the right side,
with the density compatible with fat.
(large arrow) The other mass is of a
cystic structure and is located next to
the previous one. (Small arrow). B.
Case 2. There is an obstruction of the
right bronchus intermedius with an
atelectasis and a pleural effusion.
FIGURE 2. A and B. Two examples of an en-
dobronchial lipoma. A. A yellow mass in the
right lower lobe bronchus. B. A “polyplike” en-
dobronchial tumor obstructing the bronchus
Intermedius.
FIGURE 3. Endobronchial biopsy specimens.
A. A fragment of respiratory epithelium with-
out cytonuclear atypia with fat tissue located
centrally. There are univacuolar mature fat
cells, uniform in form and size, so the diagno-
sis of an endobronchial lipoma is made. B. A
fragment of respiratory epithelium. There is
normally differentiated adipose tissue, consist-
ing of adult adipocytes. There is a varying de-
gree of fibrosis. The specimen is identified as
an endobronchial lipoma.
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Intrapulmonar lipomas are extremely rare. There are
only nine published cases. The most common parenchymal
location is in the periphery surrounded by normal lung tissue.
They typically give no complaints and grow until they are
noticed as a sharp delineated lesion on a chest radiograph. At
CT they are well differentiated lesions with a homogeneous
fat attenuation.
Endobronchial lipomas are very rare. Their incidence
ranges from 0.1 to 0.5% of all pulmonary tumors. A total of
3.2 to 9.5% of all benign endobronchial tumors are lipomas.
Muraoka et al.4 published a series of 64 cases in Japan.
Seventy-five percent of patients are symptomatic with cough
as the most frequent complaint. The other symptoms include:
increased sputum, hemoptysis, fever, and dyspnea. Eighty
percent of patients have abnormalities on chest radiograph
(e.g., atelectasis, consolidation, or mass).
The accuracy in making the diagnosis of lipoma by
bronchial biopsy is low (31%).4 The presence of a thick
fibrous capsule makes it hard to obtain a good biopsy spec-
imen, as was the case in our second patient. In such cases
helical CT can be of value.5 By describing its imaging
characteristics (a pedunculated homogeneous lesion with at-
tenuation of around–100 HU) a diagnosis of a lipoma can be
made. The definitive diagnosis, however, is often made after
surgical treatment. Resection by bronchoscopy is consid-
ered the first choice of treatment. It can be performed by
snaring forceps or laser therapy during rigid bronchos-
copy. Recurrence rate is low.4 In the Japanese series of 64
patients with an endobronchial lipoma, 17 of them re-
ceived an endobronchial procedure. None of them devel-
oped a recurrence.
Nassiri et al.6 performed a retrospective multicenter
study investigating the role of interventional broncho-
scopic techniques in the management of endobronchial
lipomas between 1981 and 2002. Thirty-six of 38 patients
underwent a rigid bronchoscopic intervention. The majority
of lipomas were removed by lasering and mechanical debulking
(76.3%). There was no recurrence in the follow-up period.
Sometimes surgical resection is indicated in case of
diagnostic difficulties (such as the presence of extrabronchial
growth, destructive lung disease due to long term atelectasis
or pneumonia, and difficulties to obtain a good histologic
sample).
In one of our patients an endobronchial lipoma was
associated with a hilar lipoma, an association that was never
described before.
CONCLUSION
Endobronchial lipomas are rare benign tumors. The
accuracy of a transbronchial biopsy is low due to the presence
of a thick fibrous capsule. Demonstration of homogeneous fat
attenuation by CT imaging can guide the differential diagno-
sis. If the endobronchial lipoma causes symptoms, then re-
section by bronchoscopy is the first choice of treatment.
Lipomas have no premalignant connotation and the local
recurrence rate is low.
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